These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8971574)

  • 1. Molecular genetic approach to the pathophysiology of cardiovascular disease.
    Kurabayashi M; Yazaki Y
    Int Angiol; 1996 Sep; 15(3):187-94. PubMed ID: 8971574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of DNA polymorphism in the renin-angiotensin system and the pathogenesis of cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1997; 51(2):171-83. PubMed ID: 9235564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease].
    Spiering W; Kroon AA; Vreugdenhil HA; Geraedts JP; Daemen MJ; de Leeuw PW
    Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1445-50. PubMed ID: 9752056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic predisposition to cardiovascular diseases].
    Stajszczyk M; Gmiński J
    Przegl Lek; 2000; 57(1):48-51. PubMed ID: 10907371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
    Corvol P; Soubrier F; Jeunemaitre X
    Pathol Biol (Paris); 1997 Mar; 45(3):229-39. PubMed ID: 9296068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease?
    van Geel PP; Pinto YM; Buikema H; van Gilst WH
    Eur Heart J; 1998 Jul; 19 Suppl G():G13-7. PubMed ID: 9717050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy in heart diseases].
    Tanner FC; Largiadèr T; Yang Z; Lüscher TF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1784-91. PubMed ID: 10603653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view.
    Kunes J; Zicha J
    Clin Sci (Lond); 2006 Nov; 111(5):295-305. PubMed ID: 17034366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology.
    Jeannesson E; Siest G; Zaiou M; Berrahmoune H; Masson C; Visvikis-Siest S
    Cell Biol Toxicol; 2009 Dec; 25(6):561-71. PubMed ID: 19067187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [I/D polymorphism of the ACE gene: a cardiovascular risk marker or error in molecular genetics?].
    Cesari M; Rossi GP
    G Ital Cardiol; 1997 Oct; 27(10):1044-52. PubMed ID: 9410774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular aspects of congenital heart diseases].
    Bajolle F; Zaffran S; Bonnet D
    Arch Mal Coeur Vaiss; 2007 May; 100(5):484-9. PubMed ID: 17646780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of the renin-angiotensin-aldosterone system: molecular and epidemiogenetic aspects].
    Soubrier F
    Nephrologie; 1998; 19(7):377-84. PubMed ID: 9857371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE2: A novel therapeutic target for cardiovascular diseases.
    Der Sarkissian S; Huentelman MJ; Stewart J; Katovich MJ; Raizada MK
    Prog Biophys Mol Biol; 2006; 91(1-2):163-98. PubMed ID: 16009403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and proteomic approaches for targeting of angiotensin-converting enzyme2 for cardiovascular diseases.
    Ferreira AJ; Raizada MK
    Curr Opin Cardiol; 2008 Jul; 23(4):364-9. PubMed ID: 18520721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting genes in the renin-angiotensin system.
    Le TH; Coffman TM
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):57-63. PubMed ID: 18090671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism of the angiotensin I-converting enzyme gene in Moscovites with arterial hypertension and cardiovascular diseases].
    Chistiakov DA; Demurov LM; Kondrat'ev IaIu; Kobalava ZhD; Tereshchenko SN; Moiseev VS; Nosikov VV
    Mol Biol (Mosk); 1998; 32(3):410-5. PubMed ID: 9720062
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial cell damage and angiotensin-converting enzyme insertion/deletion genotype in elderly hypertensive patients.
    Kario K; Matsuo T; Kobayashi H; Kanai N; Hoshide S; Mitsuhashi T; Ikeda U; Nishiuma S; Matsuo M; Shimada K
    J Am Coll Cardiol; 1998 Aug; 32(2):444-50. PubMed ID: 9708474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of angiotensin-converting enzyme insertion-deletion polymorphism on progression of renal and cardiovascular diseases].
    Reiterová J; Tesar V; Merta M
    Cas Lek Cesk; 2001 May; 140(9):267-71. PubMed ID: 11417193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.